Supplimentary 2 : Key Features of the Studies Included in This Review

Supplimentary 2 : Key features of the studies included in this review

Author Location / Study Study Sample MS Overall Prevalence MS components Setting Year Design Size Definitions Prevalence

1 Zahid Pakistan/ 2006 Cross-sectional 1658 IDF, IDF: 40% High FPG: 18.3%

et al. 2008 rural (≥20 yrs) ATPIII (M:13%, F:50% ) (M: 14.7%,F:20.4%)

F: 63.9% ATPIII: 31% Low HDL: 79.6%

(M:20%, F:40%) (M:72.8%,F:83.4%)

High TG: 29.4%

(M:24.3%,F:32.2%)

2.Sharma Nepal NM Cross-sectional 2191 IDF, IDF:22.5% Available only in

et al. 2011 (≥20 yrs) ATPIII (M:17.1%, F:25.7%) figure without F: 63.2% ATPIII: 20.7% providing exact (M:18.6%,F:21.9%) proportion

3. Rahim Bangladesh/ 2004 Cross-sectional 3981 IDF, IDF: 11.2% NM

et al. 2007 rural (≥20 yrs) ATPIII, (M:4.3%, F:15.7%) F: 59.9% WHO ATPIII: 20.7% (M:14.3%, F:25.1%) WHO: 8.6% (M:7.6%,F:9.2%)

4. Bhowmik Bangladesh/ 2009 Cross-sectional 2293 ATPIII ATPIII: 30.7% NM

et al.2013 rural (≥20 yrs) (M:30%, F:31.1%)

F: 63.3%

5. Katulanda Sri Lanka/ 2005/6 Cross-sectional 4485 IDF IDF: 27.1% HT: 81.1%

et al. 2012 urban &rural (≥18 yrs) (M:18.4%, F:28.3%) Low HDL: 77.0%

F: 60.5% Age-adjusted High TG: 55.1%

Overall: 24.3%

Urban: 34.8%, Rural: 21.6%

6. Chackrewarthy Sri Lanka/ 2007 Cross-sectional 2985 IDF, Age & Sex adjusted High FPG: 65.1%

et al. 2013 urban (35-65yrs) Modified Mo. ATPIII: 46.1% (M:66.5% F: 63.9% F:54.5% ATPIII (M:33.9%,F:56.1%) HT: 57.8%

IDF: 38.9% (M:56.3%,F:58.9%)

(M:22.9%,F:45.8%) CO (Asian WC cut-off):

54.4%

(M:35.1%,F:70.2%) Low HDL: 31.6% (M:7.4%,F: 51.5%) High TG: 31% (M:33%,F:27.6%)

7. Deepa India/ NM Cross-sectional 2350 IDF, IDF: 25.8% High FPG: 20.9%(IDF),

et al. 2007 urban (≥20 yrs) ATPIII, (M:23.1%, F:28.2% 14.7%(ATPIII)

F: 53% WHO ATPIII: 18.3% CO:57%(WHO),49.2%

(M:17.1%, F:19.4%) (IDF), 18.5% (ATPIII) WHO: 23.2% HT: 20% (WHO), (M:27.3%, F:19.7%) 31.2% (IDF, ATPIII)

High TG: 25.2%

(M:31%,F:20.1%)

Low HDL:63.5%

(M:55.4%,F:70.6%)

Dyslipidemia: 41.7%

(WHO)

8.Gupta India/ NM Cross-sectional 1091 ATPIII ATPIII:31.6% High FPG: 16.5%

et al. 2004 urban (≥20 yrs) (M:22.9%, F:39.9%) (M:16.9%,F:16.1%)

F: 51.2% Age adjusted HT: 47.2%

Overall: 24.9% (M:41.4%,F:40%) (M:18.4%,F:30.9%) Low HDL: 72.9%

(M:54.9%,F:90.2%) High TG: 30.4% (M: 32.3%,F:28.6%) CO: 33.2% (M:21.8%, F:44%)

9.Gupta India/ 2008/10 Cross-sectional 739 ATP III Age-adjusted High FPG: 13.4%

et al. 2012 urban (20-59 yrs) ATPIII: 24.2% (M:15.5%,F:10.8%)

F: 38.9% (M:25.1%, F:22%) HT: 34.4%

(M:39.5%,F:24.6%) High TG: 32.8% (M:37.6%,F:23.1%) Low HDL: 31.7% (M:25.1%,F:43.7%)

CO:18.1% (M:12.9%,F:26.6%)

10.Misra India/ 2005/7 Cross-sectional 1082 IDF, IDF: 23.9% High FPG: 28%

et al. 2011 urban & rural (≥ 18 yrs) ATPIII (M:20.6%,F:26.1%) (M:33.1%,F:24.6%)

F: 60% ATP III: 18.9% HT: 30% (M: 12.3%,,F: 23.5%) (M:33.3%,F:27.8%) Low HDL: 31.9% (M:2.8%,F:51.2%) High TG: 30.9% (M: 35.9%,F: 27.5%) CO: 22.2% (M:12.3%,F:28.8%) CO (Asian WC cut-off): 43.8% (M:40.3%,F:46.1%)

11.Prabhakaran India/ 1991/95 Cross-sectional 4044 ATPIII, Age-adjusted High FPG:9.2%,

et al. 2007 urban & rural (35-64 yrs) Modified ATPIII:24.6% (M:10.1%,F:8.3%)

F: 51.9% ATP III (M:22.2%,F:26.8%) HT: 22.9% Mo.ATPIII:27.1% (M:22.2%,F:23.6%)

(M:27.4%,F:26.8%) Low HDL: 68.3% (M:58%,F:78%) High TG: 38.9% (M: 41.4%,F: 36.7%) CO: 14.3% (M:9.4%, F: 18.9%)

12.Ravikiran India/ NM Cross-sectional 2225 ATPIII, ATPIII:35.8% High FPG: 40.1%

et al. 2010 urban (≥20 yrs) Modified (M:27.7%,F:43.2%) (M:38.5%,F:41.6%)

F: 52% ATPIII, Mo. ATPIII:45.3% HT: 58.5%

IDF (M:39.2%,F:50.9%) (M:61.9%,F:55.4%)

IDF: 39.8% Low HDL: 45.5%

(M:31.8%,F:47.2%) (M:27.2%,F:62.4%)

Age-adjusted High TG: 39.1% ATPIII:16.9% (M:39%,F:39.1%) Mo. ATPIII: 22.3% CO (Asian WC cut-off): IDF: 19.4% 60.3%

(M:52.2%,F:67.8%)

CO:31.6%

(M:16.3%, F: 45.6%)

13.Sarkar India/ NM Cross-sectional 563 ATPIII ATP III: 25.7% High FPG: 10.5%

et al. 2005 urban & rural (>20 yrs) (M:20.9%, F:51.4%) (M:11.6%,F:9.5%)

F: 54.2% High TG: 42.8%

(M:52%, F: 60.4%) Low HDL: 74.2% (M:61.2%, F: 85.2%) CO: 13.3% (M: 1.5%,F: 23.3%)

14.Sawant India/ NM Cross-sectional 548 Modified Mo.ATP III: 19.5% High FPG: 39.9

et al. 2011 urban (>20 yrs) ATP III (M:25.2%, F:12.6%) High TG: 38.1% F: 44.8% Low HDL: 47.9%

CO (Asian WC-cut off): 70.9%

15.Fall India/ 1998/2002 Longitudinal 1492 Modified Mo. ATPIII: 29.1% High FPG: 39.3%

et al. 2008 urban (26-32 yrs) ATP III (M:35.6%, F:20.2%) (M:41.3%,F:36.6%)

F: 41.7% High TG: 28.4%

(M:41.2%, F: 10.6%) Low HDL: 43% (M:34.2%, F: 55.6% CO (Asian WC cut-off): 48.9%, (M:51.5%, F:45.5%)

16.Prasad India/ 2001 Cross-sectional 1178 Modified Mo. ATPIII: 43.2% High FPG: 31.2%

et al. 2012 urban (>20 yrs) ATP III (M:34.2%, F:52.2%) (M:33.4%,F:42.3%)

F: 49.9% Age-adjusted High TG: 37.7%

Mo. ATPIII: 33.5% (M:39.3%, F: 36.1%) (M:24.9%, F:42.3%) Low HDL: 46.9% (M:9.5%, F: 84.5%) HT: 63.1%

(M:69.3%, F: 56.8%)

CO (Asian WC cut-off): 48.9% (M:41.9%, F: 56.0%)

Abbreviations: MS: Metabolic Syndrome, NM: Not Mentioned, High FPG: High Fasting Plasma Glucose, High TG: High Triyglycerides, HT: Hypertension, CO: Central Obesity, Low HDL: Low High Density Lipoprotein, WC: Waist Circumference